All Type of News
2003 conversion index of medical institutions announced
The Ministry of Health and Welfare announced the conversion index of medical institutions in 2003 ahead of the medical treatment and dispensing charges contract between the medical institutions committee and the...
BMS and Boryung to extend distribution agreement for 5 more years.
BMS Korea and Boryung agreed on Nov. 5 that the exclusive distribution agreement for BMS's 10 licensed products including Duricef Cap, an antibiotic originally effected from Oct. 1998 for 5 years would extend 5 more y...
KPA to retort KMA's misleading advertising.
The Korea Pharmaceutical Association (KPA) pointed out that the Korea Medical Association (KMA) took deceptive tricks to hurt the pharmacist community through their recent misleading public advertising largely in an a...
MOHW to finalize relative value point system.
The MOHW finally decided the health insurance relative value points according to the report presented by the assigned study.
The MOHW took the NHI policy deliberation council's meeting on Nov. 5 and passed the pla...
Public hearing not acceptable for reference price system.
The public hearing took place on Nov. 1 over the reference drug price system but faced with overall negative reactions from all participants due largely to the heavier people's financial burdens and the increased medi...
Abolition of product license system related to drugs for clinical trial purpose eyed
The Ministry of Health and Welfare announced on November 5 the revised degree of the enforcement regulations of the Korean Pharmaceutical Affairs Law, the salient points of which are as follows:
- For those patient...
Glivec's copy products and compulsory enforcement
As the Korean leukemia patients group continued to make their struggle for lowering the reimbursed price of Glivec after discontinuing the pricing negotiation with Novartis Korea, the Korean government's decision on t...
Criteria for administrative disposition to be ameliorated
The Korea Food and Drug Administration (KFDA) plans to significantly ameliorate the current criteria for administrative disposition to ensure the effectiveness and transparency in the drug-related administration.
T...
RPS is too early yet to implement
In November 1st public hearing of the Ministry of Health and Welfare on the envisaged reference price system held on the Korean Institute of Health and Social Affairs, the majority of panelists urged the government to...
KFDA's pictures for promotional strategy of drug industrial development.
The KFDA picked up 109 strategic subjects for the drug industrial development projects, which foster the industry to be the 21th century core country over the world in the field of new drug R&D and enhance the industr...
